<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00870909</url>
  </required_header>
  <id_info>
    <org_study_id>2008-A01226-49</org_study_id>
    <nct_id>NCT00870909</nct_id>
  </id_info>
  <brief_title>Transcranial Direct Current Stimulation (tDCS) and Hallucinations in Schizophrenia</brief_title>
  <official_title>Anodal &amp; Cathodal tDCS for Treatment of Resistant Auditory Hallucinations in Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital le Vinatier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital le Vinatier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether trans Direct Current Stimulation (tDCS) is
      effective in the treatment of auditory hallucinations in schizophrenia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The project will investigate the use of a novel technique, transcranial direct current
      stimulation (tDCS) in the treatment of patients with schizophrenia. tDCS permit the
      application of an extremely weak continuous electrical current to the brain through an anode
      and a cathode applied on the scalp. Anodal stimulation appears to increase brain activity
      whereas cathodal stimulation has the opposite effect.

      Using anodal &amp; cathodal tDCS the investigators aimed to treat auditory hallucinations, a
      symptoms of schizophrenia. The investigators plan to apply tDCS such that it can
      simultaneously increased activity in the frontal brain areas and reduce activity over
      temporoparietal cortex, 2 areas involved in the physiopathology of the disease. Real active
      stimulation will be compare to a sham condition in 60 patients (30 in each group). 30
      patients will be included in a French center (Hospital le Vinatier, sponsor of the study) and
      30 in Tunisia (laboratory &quot;vulnerability to psychosis&quot; (Pr Gaha) à Monastir).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2, 2009</start_date>
  <completion_date type="Actual">July 20, 2016</completion_date>
  <primary_completion_date type="Actual">April 21, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Auditory hallucinations measured by Auditory Hallucination Rating Scale (Hoffman et al., 2003)</measure>
    <time_frame>before, after 1 week of treatment and 2 times follow up (1 &amp; 3 months)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurochemical impact of treatment measured by 1H-MRS (proton Magnetic Resonance Spectroscopy), DTI (Diffusion Tensor Imaging) and resting MRI</measure>
    <time_frame>3 times: before treatment, immediately after treatment and a last evaluation 1 month after</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">46</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Auditory Hallucinations</condition>
  <arm_group>
    <arm_group_label>active tDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tDCS active; - Intensity = 2 milliamps (mA) during 20 minutes. ramp up/ramp down 30sec anodal tDCS applied over the left DLPFC combined with cathodal tDCS applied over the left temporoparietal junction (TPJ).
10 sessions, 2 per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham tDCS</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>tDCS placebo same electrode montage than in the active group. 30 sec of active tDCS in the beginning of the stimulation sessions; ramp up/ramp down 30 sec</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>active tDCS</intervention_name>
    <description>Intensity 2 mA during 20 minutes, 2 times per day</description>
    <arm_group_label>active tDCS</arm_group_label>
    <other_name>tDCS</other_name>
    <other_name>transDirect Current Stimulation</other_name>
    <other_name>Anodal tDCS</other_name>
    <other_name>Cathodal tDCS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sham tDCS</intervention_name>
    <description>sham condition as delivered by the stimulator</description>
    <arm_group_label>sham tDCS</arm_group_label>
    <other_name>tDCS placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Schizophrenia according to Diagnostic and Statistical Manual - DSM-IV

          -  Auditory verbal hallucinations for at least 6 weeks (despite antipsychotic drugs)

          -  Medication Resistance according to Kane et al., 1988

          -  Age between 18 and 50 years old

          -  Informed consent

        Exclusion Criteria:

          -  Concomitant major and unstable medical or neurologic illness

          -  Pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>emmanuel poulet, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Le Vinatier</affiliation>
  </overall_official>
  <overall_official>
    <last_name>JEROME BRUNELIN, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hopital le Vinatier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Le vinatier</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Laboratoire de Recherche &quot; Vulnérabilité Aux Psychoses &quot;</name>
      <address>
        <city>Monastir</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2009</study_first_submitted>
  <study_first_submitted_qc>March 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2009</study_first_posted>
  <last_update_submitted>February 28, 2017</last_update_submitted>
  <last_update_submitted_qc>February 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Hallucinations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

